Some links on this site are affiliate links. If you buy through them, we may earn a commission at no extra cost to you. Learn more

Pinealon Peptide (EDR): Benefits, Safety and the Evidence

Adrian XH
Published Author, Certificate: Medical Research

Last updated

Research use only. Nothing on this page is medical advice, and pinealon isn’t approved for human use.

Pinealon is the tripeptide Glu-Asp-Arg (EDR) from Vladimir Khavinson’s group. No randomized trial has tested it in people. The evidence is cell work, rodent and monkey studies, and small uncontrolled Russian reports. In the one study with lab safety data, pinealon given with Vesugen also showed prooxidant activity and fewer CD34+ blood stem cells (1).

An independent 2026 mouse preprint saw a trend toward better working memory and no adverse effects over 8 weeks. It isn’t peer reviewed (2).

Sequence
Glu-Asp-Arg (EDR), 418.4 g/mol by calculation
Developed by
Vladimir Khavinson’s group, St. Petersburg
Claimed target
The brain and nervous system
Human evidence
Small, uncontrolled Russian reports, mostly with Vesugen (1)
Independent trials
None found (3)
FDA status
Not approved. Not on FDA’s compounding-risk page, not reviewed by its July 2026 committee and not in HHS’s October 2026 policy (4, 5, 6)
WADA 2026
S0 catch-all for unapproved substances (7)
Public lot report

Pinealon 10 mg at Amino Club

From $49.99. Sold for laboratory research only.

99.90%HPLC purity
10.26 mgmeasured, 10 mg label
<0.05 EU/mLendotoxin limit
  • Identity confirmed by HPLC; fentanyl screen, heavy metals and sterility all pass
  • Lot PIN0002, tested by a lab the seller says is ISO 17025 accredited (8)
See the Pinealon lot report

Match the lot number on your vial to the report before you rely on it.

What is pinealon?

Pinealon is a synthetic tripeptide of glutamic acid, aspartic acid and arginine. It belongs to Khavinson’s cytogens, short peptides said to regulate one organ each, and its claimed organ is the brain. It looks like Vesugen (KED) but isn’t: pinealon has arginine where Vesugen has lysine, which makes it about 28 g/mol heavier. Our Khavinson peptides guide covers the family.

Pinealon benefits: what the studies found

None of these benefits is proven in people. The table sorts the studies by how close they are to a human.

How to read the table. Limited: small human reports from one network. Rats, Mice, Cells: lab or animal work only. Warning: a harmful signal was reported.

Pinealon research sorted by closeness to humans: model, findings and watch-outs
StudyModelWhat it reportedWatch-out
People
1Nazimko, 2012Workplace studyLocomotive crew workersLimitedAfter two weeks of pinealon capsules, biological-age and adaptation indicators improved (9)No control group in the abstract
2Bashkireva, 2012Occupational study150 truck drivers and 150 metal workersLimitedPsychoemotional indices and resistance to work stress improved, most with pinealon and Vesugen together (10)Tested as a combination, from the same research network
3Meshchaninov, 2015Small study32 people aged 41 to 83 with organic brain syndromeWarningPinealon and Vesugen improved biological-age indicators. The report also found prooxidant activity and fewer CD34+ blood stem cells, read as inhibited blood-cell formation (1)No control group in the abstract, and a safety signal
Animals and primates
4Arutjunyan, 2012Prenatal modelRat offspring after prenatal hyperhomocysteinemiaRatsPinealon given to pregnant rats improved the offspring’s learning and spatial orientation and cut oxidative stress and necrotic neurons (11)Rats, not people
5Mendzheritskii, 2014Hypoxia modelOld rats in acute hypoxiaRatsThe authors suggest pinealon raised neurogenesis and brought neuroinflammation back toward baseline (12)A suggestion from marker readings, compared with Cortexin
6Mendzheritsky, 2015Hypoxia and cold model18-month-old ratsRatsPinealon changed behavior and brain neurochemistry. Cortexin acted more strongly on free radical processes and caspase-3 (13)Cortexin was the stronger comparator
7Karantysh, 2020Memory modelRats with streptozotocin diabetesRatsOf three doses, the middle one best preserved a learned water-maze skill and changed NMDA receptor subunit genes least (14)One lab, and the effect depended on the dose
8Khavinson, 2021Alzheimer’s model, plus docking5xFAD miceMiceEDR and KED prevented dendritic spine loss in male mice. Docking placed EDR on promoter regions of genes such as CASP3, GAP43 and SOD2 (15)Docking is a simulation, and figures were corrected in 2025 (16)
9Trofimova, 2025ReviewPrimate studiesPrimatesA review says pinealon improves cognitive function in primates and helps restore neuroimmunoendocrine balance (17)Review of mostly Khavinson-school work, with no numbers in the abstract
10Marin-Jerez, 2026Preprint, independent groupMice for 8 weeks, five compoundsMicePinealon showed a trend toward better working memory with no detectable adverse effects (2)Not peer reviewed, and a screening study, not a memory trial
Cells
11Khavinson, 2011Oxidative stressCerebellar granule cells, neutrophils and PC12 cellsCellsPinealon lowered reactive oxygen species in a dose-dependent way, cut necrotic death, delayed ERK 1/2 activation and changed the cell cycle (18)The authors infer a direct genome interaction from the dose pattern
12Kraskovskaya, 2017Amyloid stressMouse hippocampal neuronsCellsEDR raised mushroom spines by 71% and returned them to the normal level (19)Cultured neurons
13Kraskovskaya, 2024Neuronal aging modelNeurons made from elderly donors’ fibroblastsCellsEDR raised total dendrite length by 46% and primary dendrites by 28%, and lowered oxidative DNA damage. Mitochondria, lysosomes and p16 didn’t change (20)One lab model

You may see a 72-patient brain injury trial cited for pinealon. A 2019 paper mentions it, traces it to a 2008 Eurasian patent and describes no control group (21). ClinicalTrials.gov lists no registered pinealon trial (3).

How might pinealon work?

The group proposes that pinealon enters cells and binds DNA, which comes from test-tube and computer work. Fluorescent short peptides, pinealon among them, entered the nucleus of HeLa cancer cells (22). NMR and simulations show EDR can interact with DNA, and the interaction depends on the surrounding ions (23). The group’s own review proposes changes in genes such as SOD2, GPX1 and caspase-3 (24), and docking suggests amino acid and peptide transporters could carry EDR into cells (25).

None of this was shown in a living person.

Pinealon dosage: is there one?

No validated human dose exists. The human reports used capsules in short courses, such as two weeks in the locomotive study (9). No study compared oral with injected pinealon, and no trial supports a cycling schedule such as 10 to 30 days on and months off. Our guide on whether short peptides work orally covers the open question.

Pinealon safety and side effects

Nobody has run a safety trial. The one human signal comes from the 32-patient study: prooxidant activity and fewer CD34+ cells, read by the authors as inhibited blood-cell formation (1). The same abstract found no change in chromatin condensation, which is a single lab measure and doesn’t show pinealon is safe for DNA.

Side-effect lists on seller sites, such as headache, vivid dreams and nausea, cite no source. No data exist for pregnancy or breastfeeding, so avoid pinealon then, and talk to a doctor if you take any medicine.

No. FDA hasn’t approved pinealon, and it doesn’t appear on FDA’s list of bulk substances that may present significant safety risks (4). It wasn’t among the seven peptides FDA’s advisory committee reviewed in July 2026 (5), and HHS’s 28 October 2026 interim policy covers six other peptides and excludes research chemicals (6). WADA’s 2026 List doesn’t name pinealon, but S0 bans any substance without regulatory approval (7).

Where to buy pinealon: what to check on the lot report

Amino Club sells pinealon for laboratory use and publishes a lot report for it. The report listed above is a good model of what to look for in any seller’s paperwork.

  • The lot number on the report matches your vial.
  • The report shows measured content in milligrams, not only a purity percentage. Here 10.26 mg was measured against a 10 mg label.
  • Identity is confirmed, and endotoxin, sterility and heavy-metals results are listed.
  • The lab’s own site or the seller’s library confirms the report.

Our guide to verifying a peptide COA explains each line, and best peptide vendors compares sellers by what their lab reports show.

Checked the list above? Amino Club’s Pinealon listing links the full ten-assay report.

Open the Amino Club listing

Pinealon FAQ

What is pinealon peptide?

Pinealon is the tripeptide Glu-Asp-Arg (EDR) from Vladimir Khavinson’s group. It is studied in cells and animals for neuroprotection and has no approved use.

Does pinealon work?

No randomized trial exists. Small Russian reports and lab studies suggest effects, but nothing is confirmed in people.

What are the benefits of pinealon?

None is proven in humans. In rats, mice and cell cultures it lowered oxidative stress and protected dendritic spines, and one independent mouse preprint saw a trend toward better working memory.

What is the pinealon dosage?

No validated human dose exists. The human reports used capsules in short courses, and no trial supports a cycling schedule.

Is pinealon safe?

Unknown. One 32-patient study found prooxidant activity and fewer CD34+ blood stem cells, and no long-term safety studies exist.

Does pinealon help with sleep or anxiety?

No abstract reports a sleep measure. A 2012 study of truck drivers reported better psychoemotional scores with pinealon and Vesugen together, without a placebo group in the abstract.

Does pinealon change your DNA?

It interacts with DNA in test-tube and computer studies. No human study shows it changes genes in people.

Can pinealon help with Alzheimer’s disease?

Only mouse and cell studies exist, and no human trial has tested it.

How does pinealon compare with epitalon?

Epitalon is a four-amino-acid peptide from the same group, studied for the pineal gland and telomeres. A 2025 cell study found it lengthened telomeres in breast cancer cells too. The evidence for both is mostly lab work and Russian reports.

Is pinealon banned in sport?

WADA’s 2026 List doesn’t name it, but S0 bans any substance without regulatory approval, so tested athletes should treat it as prohibited.

Keep researching: the Khavinson peptides guide, Vesugen, Epitalon, Pancragen, the full list of peptides and bioregulator capsules.

References

Show references (25)Hide references
  1. Meshchaninov VN, et al. Effect of synthetic peptides on aging of patients with chronic polymorbidity and organic brain syndrome in remission. Adv Gerontol 2015. Source
  2. Marin-Jerez E, et al. Short-term performance assay identifies functional benefits and early toxicity of longevity interventions in mice. Preprint, 2026. Source
  3. ClinicalTrials.gov search for pinealon: no registered trials. Source
  4. FDA. Certain bulk drug substances for use in compounding that may present significant safety risks (content dated 22 April 2026). Source
  5. Healio. FDA committee recommends looser restrictions for several peptides. 24 July 2026. Source
  6. BakerHostetler. HHS issues enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances. 28 October 2026. Source
  7. WADA. The 2026 Prohibited List. Source
  8. Amino Club. Certificate of analysis library, Pinealon 10 mg lot PIN0002. Source
  9. Nazimko VA, et al. Analysis of some parameters of biological age and adaptation possibilities of workers of locomotive brigades. Adv Gerontol 2012. Source
  10. Bashkireva AS, Artamonova VG. The peptide correction of neurotic disorders among professional truck-drivers. Adv Gerontol 2012. Source
  11. Arutjunyan A, et al. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. Int J Clin Exp Med 2012. Source
  12. Mendzheritskii AM, et al. Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon. Adv Gerontol 2014. Source
  13. Mendzheritsky AM, et al. Pinealon and Cortexin influence on behavior and neurochemical processes in 18-month aged rats within hypoxia and hypothermia. Adv Gerontol 2015. Source
  14. Karantysh G, et al. Effect of pinealon on learning and expression of NMDA receptor subunit genes in the hippocampus of rats with experimental diabetes. Neurochem J 2020. Source
  15. Khavinson V, et al. Neuroprotective effects of tripeptides-epigenetic regulators in mouse model of Alzheimer’s disease. Pharmaceuticals 2021. Source
  16. Correction to Khavinson et al., Pharmaceuticals 2021. Pharmaceuticals 2025. Source
  17. Trofimova SV, Kuznetsova TG, Trofimov A. Effects of short peptides on the molecular mechanisms of aging in laboratory primates. Mol Med 2025. Source
  18. Khavinson V, et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Res 2011. Source
  19. Kraskovskaya NA, et al. Tripeptides restore the number of neuronal spines under conditions of in vitro modeled Alzheimer’s disease. Bull Exp Biol Med 2017. Source
  20. Kraskovskaya N, et al. Short peptides protect fibroblast-derived induced neurons from age-related changes. Int J Mol Sci 2024. Source
  21. Kuznik BI, et al. Epigenetic mechanisms of peptide-driven regulation and neuroprotective protein FKBP1b. Mol Biol 2019. Source
  22. Fedoreyeva LI, et al. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow) 2011. Source
  23. Silanteva IA, et al. Role of mono- and divalent ions in peptide Glu-Asp-Arg-DNA interaction. J Phys Chem B 2019. Source
  24. Khavinson V, et al. EDR peptide: possible mechanism of gene expression and protein synthesis regulation involved in the pathogenesis of Alzheimer’s disease. Molecules 2020. Source
  25. Khavinson VK, et al. Feasibility of transport of 26 biologically active ultrashort peptides via LAT and PEPT family transporters. Biomolecules 2023. Source